Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
13.73
0.00 (0.00%)
At close: Aug 12, 2026, 4:00 PM EDT
13.72
-0.01 (-0.07%)
After-hours: Aug 12, 2026, 4:15 PM EDT
Carlsmed Revenue
Carlsmed had revenue of $18.94M in the quarter ending June 30, 2026, with 56.75% growth. This brings the company's revenue in the last twelve months to $63.30M, up 65.39% year-over-year. In the year 2025, Carlsmed had annual revenue of $50.51M with 85.94% growth.
Revenue (ttm)
$63.30M
Revenue Growth
+65.39%
P/S Ratio
5.84
Revenue / Employee
$498,386
Employees
127
Market Cap
374.87M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50.51M | 23.35M | 85.94% |
| Dec 31, 2024 | 27.17M | 13.39M | 97.16% |
| Dec 31, 2023 | 13.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
CARL News
- 7 hours ago - Carlsmed Transcript: Bank of America SMID Cap Virtual Conference - Transcripts
- 6 days ago - Carlsmed price target raised to $20 from $18 at Truist - TheFly
- 7 days ago - Carlsmed Earnings Call Transcript: Q2 2026 - Transcripts
- 7 days ago - Carlsmed Earnings release: Q2 2026 - Filings
- 7 days ago - Carlsmed Quarterly report: Q2 2026 - Filings
- 7 days ago - Carlsmed reports Q2 EPS (39c), consensus (40c) - TheFly
- 7 days ago - Carlsmed raises FY26 revenue view to $74M-$78M from $72M-$77M - TheFly
- 7 days ago - Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance - GlobeNewsWire